SRA1 anticorps (C-Term)
Aperçu rapide pour SRA1 anticorps (C-Term) (ABIN7452064)
Antigène
Voir toutes SRA1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Fonction
- Rabbit anti-SRA Antibody, Affinity Purified
-
Purification
- Affinity Purified
-
Immunogène
- between AA 180 and C-term
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- SRA1 (Steroid Receptor RNA Activator 1 (SRA1))
-
Autre désignation
- SRA
-
Sujet
- Background: Steroid receptor RNA activator 1 (SRA) was originally identified as a functional non-coding RNA that has been shown to be a coactivator of steroid receptors for androgens (AR), estrogens (ER), glucocorticoids, and progestins (PR). SRA exists in ribonucleoprotein complexes with steroid receptor coactivators (SRCs) and steroid receptors and may modulate transcriptional specificity. A 236 amino-acid protein encoded by an SRA-RNA isoform has also been identified. The SRA protein (SRAP) is widely expressed in breast cancer cell lines and breast cancer and has been demonstrated to modify the activity of the estrogen receptor.
-
ID gène
- 10011
-
NCBI Accession
- NP_001030312
-
UniProt
- Q9HD15
-
Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
Antigène
-